Australia, Nov. 11 -- Vertex Pharmaceuticals Inc., owns the trademark (2581535) for 'LIFVOCIO' till July 22, 2035.
Status: protected:
Registered/protected
Class: 5 [Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated kidney disease.]
Type of Mark: Word
Date of Acceptance: Sept. 3
Registration Advertised: Nov. 10
For further details contact Sarah Anne Keefe Womble Bond Dickinson (US) LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2581535.
Disclaimer: Curated by HT Syndication....